In this episode, we are joined by Drs. Thellea Leveque and Steven Yeh to discuss the myriad of considerations while managing retinal vasculitis. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Veena Raiji and Edmund Tsui to discuss Multifocal Choroiditis (MFC) and Punctate Inner Choroidopathy (PIC). The authors report no relevant financial disclosures.

In this episode, we are joined by Drs. Jennifer Cao and Robert Swan to discuss a systematic approach to the diagnosis, monitoring and treatment of ocular cicatricial pemphigoid. The discussants report no relevant financial disclosures.

In this episode, we are joined by pediatric ophthalmologist and uveitis specialist Dr. Ginny Utz and pediatric rheumatologist Dr. Sheila Angeles-Han to discuss a multidisciplinary approach to the management of JIA-associated uveitis. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Mamta Agarwal and Miel Sundararajan to discuss the medical and surgical approaches to managing infectious scleritis. The discussants report no relevant financial disclosures.

In this episode, we summarize several key clinical research papers from 2024. The discussants report no relevant financial disclosures.

In the second part of this two-part series, we continue our discussion with Drs. Eric Suhler and George Mount regarding the use of biologics for the management of non-infectious uveitis. Disclosures: Dr. Suhler has consulted for Abbvie

In the first part of this two-part series, we are joined by Drs. Eric Suhler and George Mount to discuss the use of biologics for the management of non-infectious uveitis.Disclosures:Dr. Suhler has consulted for Abbvie

In this episode, we are joined by uveitis specialist, Dr. Lyndell Lim and maternal-fetal medicine specialist, Dr. Kelly Kuo to discuss management of uveitis in pregnant patients. The discussants report no relevant financial disclosures.

In this episode, we are joined by pulmonologist, Dr. Amy Malik and uveitis specialist, Dr. Ananth Sastry to discuss the ocular and systemic considerations in sarcoidosis. The discussant report no relevant financial disclosures.

In this episode, we are joined by Drs. Lucia Sobrin and Tim Boyce to discuss the perplexing condition that is autoimmune retinopathy. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Meghan Berkenstock and Meredith McKean to discuss uveitis secondary to immune checkpoint inhibtor use.

In this episode, we are joined by Drs. John Kempen and Sapna Gangaputra to review the many ways the SITE cohort study has shaped the way we approach uveitis. Drs. Kempen and Gangaputra have received grant support from the NIH for their work on the SITE cohort study.

In this episode we are joined by Drs. Debra Goldstein and Mark Dacey to discuss the manifestations, treatment approach and special considerations for ocular syphilis. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Jennifer Thorne and Parisa Emami to discuss diagnostic and therapeutic approaches in the management of uveitic CNV. Disclosures: Dr. Kopplin: None Dr. Thomas: Consultant for Allergan, Genentech Dr. Thorne: None Dr. Emami: Consultant for Genentech

Here we are joined by Drs. Justine Smith and Emilio Dodds to discuss the clinical features and treatment approach in toxoplasma chorioretinitis. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Alan Palestine and Karen Armbrust to discuss the approach the diagnosis and managament of the many forms of scleritis. The discussants report no relevant financial disclosures.

Today we are joined by Drs. Rupesh Agrawal and Dilraj Grewal to discuss the myriad of clinical findings and treatment approaches in ocular tuberculosis. The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Arjun Sood and Sruthi Arepalli to discuss diagnostic and therapeutic approaches in the management of uveitic macular edema. Disclosures: Dr. Kopplin: Principal Investigator in clinical study sponsored by Roche Dr. Thomas: Principal Investigator in clinical studies sponsored by Roche and Alimera. Consultant for Alimera, Allergan, EyePoint Dr. Sood: Consultant for Alimera and EyePoint Dr. Arepalli: Consultant for EyePoint

Today we are joined by Drs. Jennifer Cao and Edmund Tsui to discuss the spectrum of ocular disease in VKH syndrome. The discussants report no relevant financial disclosures.